Steve Schonfeld’s Lexeo Therapeutics LXEO Stock Holding History
Bought
Maintained
Sold
Other funds holding LXEO
Steve Schonfeld's LXEO Position: Q3 2026 in Review
Steve Schonfeld opened a new position in Lexeo Therapeutics (LXEO) in Q3 2026: 45,812 shares worth $155K. The stake represents ﹤0.01% of the portfolio and ranks #2422 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in LXEO as recently as Q1 2026.
Steve Schonfeld first reported a position in LXEO in Q1 2026 and has held it in 2 quarters since. 153 funds tracked by Wall St. Rank hold LXEO as of Q3 2026.
- Steve Schonfeld held 45,812 shares of Lexeo Therapeutics worth $155K as of Q3 2026.
- Lexeo Therapeutics was a new Steve Schonfeld position in Q3 2026.
- Lexeo Therapeutics made up ﹤0.01% of Steve Schonfeld's portfolio in Q3 2026, its #2422 holding.
- Steve Schonfeld first reported a position in Lexeo Therapeutics in Q1 2026 and has held it in 2 quarters since.
- 153 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q3 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.